Boxer LM - Search Results

1

Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia.

Fine BM, Stanulla M, Schrappe M, Ho M, Viehmann S, Harbott J, Boxer LM. Fine BM, et al. Among authors: boxer lm. Blood. 2004 Feb 1;103(3):1043-9. doi: 10.1182/blood-2003-05-1518. Epub 2003 Oct 2. Blood. 2004. PMID: 14525776 Free article.

2

A genome-wide view of the in vitro response to l-asparaginase in acute lymphoblastic leukemia.

Fine BM, Kaspers GJ, Ho M, Loonen AH, Boxer LM. Fine BM, et al. Among authors: boxer lm. Cancer Res. 2005 Jan 1;65(1):291-9. Cancer Res. 2005. PMID: 15665306

3

Myb binding sites mediate negative regulation of c-myb expression in T-cell lines.

Guerra J, Withers DA, Boxer LM. Guerra J, et al. Among authors: boxer lm. Blood. 1995 Sep 1;86(5):1873-80. Blood. 1995. PMID: 7655015 Free article.

4

Translocations involving c-myc and c-myc function.

Boxer LM, Dang CV. Boxer LM, et al. Oncogene. 2001 Sep 10;20(40):5595-610. doi: 10.1038/sj.onc.1204595. Oncogene. 2001. PMID: 11607812 Review.

5

The role of oncogenes in hematologic malignancies.

Boxer LM. Boxer LM. Annu Rev Med. 1994;45:1-11. doi: 10.1146/annurev.med.45.1.1. Annu Rev Med. 1994. PMID: 8198369 Review.

6

Critical elements of the immunoglobulin heavy chain gene enhancers for deregulated expression of bcl-2.

Heckman CA, Cao T, Somsouk L, Duan H, Mehew JW, Zhang CY, Boxer LM. Heckman CA, et al. Among authors: boxer lm. Cancer Res. 2003 Oct 15;63(20):6666-73. Cancer Res. 2003. PMID: 14583460

7

The N-terminal domain unique to the long form of the Brn-3a transcription factor is essential to protect neuronal cells from apoptosis and for the activation of Bbcl-2 gene expression.

Smith MD, Dawson SJ, Boxer LM, Latchman DS. Smith MD, et al. Among authors: boxer lm. Nucleic Acids Res. 1998 Sep 15;26(18):4100-7. doi: 10.1093/nar/26.18.4100. Nucleic Acids Res. 1998. PMID: 9722627 Free PMC article.

8

Allele-specific analysis of transcription factors binding to promoter regions.

Heckman CA, Boxer LM. Heckman CA, et al. Among authors: boxer lm. Methods. 2002 Jan;26(1):19-26. doi: 10.1016/S1046-2023(02)00004-X. Methods. 2002. PMID: 12054901

9

NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer.

Kanda K, Hu HM, Zhang L, Grandchamps J, Boxer LM. Kanda K, et al. Among authors: boxer lm. J Biol Chem. 2000 Oct 13;275(41):32338-46. doi: 10.1074/jbc.M004148200. J Biol Chem. 2000. PMID: 10931834 Free article.

10

Activation of the c-myc p1 promoter in Burkitt's lymphoma by the hs3 immunoglobulin heavy-chain gene enhancer.

Hu HM, Kanda K, Zhang L, Boxer LM. Hu HM, et al. Among authors: boxer lm. Leukemia. 2007 Apr;21(4):747-53. doi: 10.1038/sj.leu.2404583. Epub 2007 Feb 8. Leukemia. 2007. PMID: 17287852

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters